| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |